Adjuvant Laboratory Marker of Kawasaki Disease; NT-pro-BNP or Hs-Crp?

Sun Young Cho,Yeongsic Kim,Sung-Ho Cha,Jin-Tae Suh,Mi Young Han,Hee Joo Lee
2011-01-01
Abstract:Background: The diagnosis of Kawasaki disease (KD) is based on clinical data and non-pathognomonic symptoms. As no specific diagnostic test for KD exists, BNP or NT-pro-BNP might be of importance in identifying KD. We compared serum hs-CRP and NT-pro-BNP level in the acute phase of 59 KD patients and evaluated the diagnostic performance of these laboratory markers in KD to estimate the cut-off level for differentiating KD from other febrile illnesses as age-matched controls. Materials and Methods: The study groups consisted of 59 KD patients in the disease group and 45 other patients with febrile illnesses as age-matched controls. NT-pro-BNP was measured using Elecsys proBNP (Roche Diagnostics, Mannheim, Germany), and hs-CRP was tested with CardioPhase hs-CRP (Siemens Healthcare Diagnostics, Marburg, Germany). Results: NT-pro-BNP levels were significantly higher in the KD patients than in the controls (P <0.001). In the ROC curve analysis, the sensitivity was 66.10%, and the specificity was 77.08% at 235.2 pg/mL. hs-CRP levels tended to be higher in KD patients compared to controls. Discussion: This study indicates that NT-pro-BNP might be a more useful laboratory marker as an adjuvant diagnostic tool for KD than hs-CRP Especially in a patient with incomplete clinical features of KID, the diagnosis and the start of treatment were delayed to confirm a fever persisting for at least 5 days. Therefore, we expect that NT-pro-BNP would be especially useful for KD patients with these atypical clinical presentations.
What problem does this paper attempt to address?